PhRMA
MAY 15, 2023
To achieve a healthier world where all people have access to life-changing medicines, we must support researchers working to advance biopharmaceutical innovation and value-driven health care. This is the purpose of the PhRMA Foundation, a 58-year-old nonprofit that catalyzes the careers of promising researchers through competitive, peer-reviewed grants and fellowships.
Drug Topics
MAY 15, 2023
Balanced products showed greater improvements compared to either CBD-dominant or THC-dominant products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MAY 15, 2023
When gastroenterologists learned in March that UnitedHealthcare plans to barricade many colonoscopies behind a controversial and complicated process known as prior authorization, their emotions cycled rapidly between fear, shock, and outrage. The change, which the health insurer will implement on June 1, means that any United member seeking surveillance and diagnostic colonoscopies to detect cancer will first need approval from United — or else have to pay out of pocket.
Pharmacy Times
MAY 15, 2023
Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MAY 15, 2023
Doing small spurts of exercise throughout the day provide numerous benefits.
Pharmacy Times
MAY 15, 2023
Approximately 56.6% of young adults with advanced heart disease prefer to be involved in end-of-life decisions if they were very ill, with nearly all patients saying that they would also like their parents to be involved.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 15, 2023
Diagnosing risk of frailty in patients hospitalized with heart failure is a safe and effective means of improving patient management.
Fierce Healthcare
MAY 15, 2023
PBGH: What employers want to see as Congress aims to reform PBMs pminemyer Mon, 05/15/2023 - 16:13
Pharmacy Times
MAY 15, 2023
Patients with HIV were no less likely to show a worse clinical presentation following tecovirimat treatment.
Drug Topics
MAY 15, 2023
Marketing costs money, so be sure to spend wisely.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 15, 2023
The sleep hormone decreased intestinal homeostasis, which may augment inflammation that causes tissue and intestinal damage.
Drug Topics
MAY 15, 2023
The trial also revealed that nirsevimab reduced the incidence of hospitalizations due to severe RSV-related LRTD by 75.1%.
The Checkup by Singlecare
MAY 15, 2023
Almost 30 million adults in the U.S. have chronic kidney disease (CKD), and about 661,000 of those affected have kidney failure requiring dialysis or transplantation, according to a 2019 study published in Advances in Nutrition. Interestingly, 24% of CKD cases are associated with poor diet. In this article, learn how your diet impacts kidney function and how to follow a kidney-friendly eating plan.
Pharmaceutical Technology
MAY 15, 2023
Sanofi announced data from a real-world clinical trial that demonstrated its RSV antibody nirsevimab delivered an 83% reduction in hospitalisations in infants with respiratory syncytial virus (RSV)-related lower respiratory tract disease (LRTD). Nirsevimab is being jointly developed between Sanofi and AstraZeneca. Along with reducing hospitalisations due to RSV-related LRTD, nirsevimab also caused a drop in hospitalisations due to severe RSV-related LRTD by 76% and all-cause LRTD by 58%.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 15, 2023
After months of anticipation, the U.S. Supreme Court declined to hear an appeal of a lower court ruling that throws into question whether generic companies can “carve out” uses for their medicines and supply Americans with cheaper alternatives to brand-name drugs. At issue is skinny labeling, which happens when a generic company seeks regulatory approval to market its medicine for a specific use, but not other patented uses for which a brand-name drug is prescribed.
Pharmaceutical Technology
MAY 15, 2023
The US Food and Drug Administration (FDA) has approved Astellas Pharma’s Veozah (fezolinetant) for use against moderate to severe vasomotor symptoms caused by menopause on May 12 after some delays due to an extended review. This marks the first-ever FDA approval of a nonhormonal neurokinin 3 (NK3) receptor antagonist for use against vasomotor symptoms caused by menopause.
STAT
MAY 15, 2023
It’s been a chaotic three years for Masimo CEO Joe Kiani. First came the pandemic, and with it, a dramatic uptick in demand for Masimo’s pulse oximetry devices. Then came the patient monitoring company’s 2022 acquisition of Sound United, a consumer audio business, which perplexed investors and sent Masimo stocks crumbling.
Pharmaceutical Technology
MAY 15, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Small molecules in Pharmaceuticals: Quinoline derivat
STAT
MAY 15, 2023
In the early days of the Covid pandemic, gravely ill patients began to fill America’s hospitals. Hospitals ran short of essential treatment medications and were unable to source those drugs from manufacturers or from the outsourcing facilities that had been authorized by Congress in 2013 to “fill the gap” in such situations. At the urging of the Alliance for Pharmacy Compounding, the trade association I lead, the Food and Drug Administration in April 2020 issued temporary gu
Fierce Healthcare
MAY 15, 2023
CVS closing down clinical trials business after 2 years pminemyer Mon, 05/15/2023 - 13:36
STAT
MAY 15, 2023
WASHINGTON — President Biden on Monday officially announced that he would nominate National Cancer Institute Director Monica Bertagnolli to fill the long-vacant director slot at the National Institutes of Health. The cancer surgeon has led NCI — NIH’s largest institute — since last October and previously led Dana-Farber Cancer Institute’s surgical oncology unit.
Fierce Healthcare
MAY 15, 2023
Union workers at 5 California HCA hospitals vote to strike dmuoio Mon, 05/15/2023 - 14:09
STAT
MAY 15, 2023
Physician staffing firm Envision Healthcare officially filed for Chapter 11 bankruptcy on Monday, a move that will wipe away $5.6 billion of debt and hand over ownership of the company to its creditors. Envision also plans on selling a separate subsidiary that runs outpatient surgery centers, and has already attracted two potential buyers. Envision’s bankruptcy serves as a warning for other physician staffing firms that have a lot of debt and previously relied on balance billing patients.
Fierce Pharma
MAY 15, 2023
UPDATED: After Supreme Court rejection, Teva mulls options in GSK 'skinny label' feud fkansteiner Mon, 05/15/2023 - 10:59
STAT
MAY 15, 2023
UnitedHealthcare and Phoenix Children’s Hospital are embroiled in a bitter contract dispute that would lock out families and children from care at the hospital by June if the two sides don’t come to a new agreement. And at least according to the hospital, the fight isn’t over prices, which is the traditional sticking point.
Drug Store News
MAY 15, 2023
For the month of April, suppliers introduced 178 new products. HRG reviewed the products to see which ones stood out as Products to Watch.
STAT
MAY 15, 2023
REDWOOD CITY, Calif. — Over two blustery spring days earlier this month, 30 hopeful tech entrepreneurs crowded into a downtown office here. Each founder had a bright idea for transforming health care with things like artificial intelligence, sensors, or video calls. What they didn’t know was how to get paid for it.
Fierce Healthcare
MAY 15, 2023
Experts call for addressing rising Black maternal mortality from all sides aburky Mon, 05/15/2023 - 18:27
STAT
MAY 15, 2023
Ghana has taken a remarkable step in the fight against malaria by becoming the first country in the world to approve the R21/Matrix-M vaccine. It’s poised to be highly effective in young children from 5 months to 36 months, the age group with the highest risk. The approval highlights the continued urgency required to combat this disease, which remains a significant threat to human health and a considerable social and economic burden.
European Pharmaceutical Review
MAY 15, 2023
Infants under 12 months who received a single dose of monoclonal antibody (mAb) nirsevimab showed an 83.21 percent reduction in hospitalisations due to respiratory syncytial virus (RSV) -related lower respiratory tract disease (LRTD), according to new real-world data from a Phase IIIb trial. Results from the Hospitalized RSV Monoclonal Antibody Prevention (HARMONIE) study were presented at 41st Annual Meeting of the European Society for Paediatric Infectious Diseases.
STAT
MAY 15, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of online calls, dashing about, and deadlines has predictably returned. But what can you do? The world, such as it is, continues to spin. So why not give it a nudge in a better direction with a delicious cup of stimulation?
Fierce Pharma
MAY 15, 2023
Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board?
Drug Store News
MAY 15, 2023
Consumers will now be able to shop the brand’s full range of products at Ulta Beauty locations and online at Ulta.com.
Fierce Pharma
MAY 15, 2023
Dermavant's Vtama hits the mark in another phase 3 eczema trial kdunleavy Mon, 05/15/2023 - 19:54
Expert insights. Personalized for you.
130 
Let's personalize your content